Sale!

SELENON Gene Myopathy with Fiber-Type Disproportion Genetic Test

Original price was: $700.Current price is: $500.

-29%

The SELENON Gene Myopathy with Fiber-Type Disproportion NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the SELENON gene responsible for a rare congenital muscle disorder. This comprehensive genetic analysis utilizes Next-Generation Sequencing technology to detect specific genetic variations associated with fiber-type disproportion myopathy. The test provides crucial diagnostic information for individuals experiencing muscle weakness, respiratory complications, and developmental delays. Early detection through this $500 USD test enables proactive management strategies and personalized treatment approaches. Our specialized neurological genetic testing includes pre-test genetic counseling to ensure comprehensive patient understanding and support throughout the diagnostic journey.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

SELENON Gene Myopathy with Fiber-Type Disproportion NGS Genetic DNA Test

Comprehensive Introduction to SELENON Gene Myopathy Testing

SELENON Gene Myopathy with Fiber-Type Disproportion represents a rare congenital muscle disorder characterized by specific histological abnormalities in muscle fiber composition. This advanced genetic test utilizes Next-Generation Sequencing (NGS) technology to identify mutations in the SELENON gene, which plays a critical role in muscle development and function. The importance of this diagnostic tool cannot be overstated, as it provides definitive answers for individuals and families affected by this challenging neuromuscular condition.

Early and accurate diagnosis through genetic testing enables healthcare providers to develop targeted management strategies, improve patient outcomes, and provide crucial genetic counseling for family planning decisions. The SELENON gene encodes selenoprotein N, which is essential for proper muscle fiber development and maintenance, making this test particularly valuable for understanding the underlying mechanisms of fiber-type disproportion myopathy.

What the Test Measures and Detects

This sophisticated genetic analysis specifically targets the SELENON gene to identify pathogenic variants associated with congenital fiber-type disproportion myopathy. The test employs comprehensive NGS technology to examine:

  • Point mutations and single nucleotide variants in the SELENON gene
  • Small insertions and deletions affecting gene function
  • Copy number variations that may impact gene expression
  • Regulatory region abnormalities influencing protein production

The detection of specific genetic mutations provides definitive diagnostic information, distinguishing SELENON-related myopathy from other neuromuscular disorders with similar clinical presentations. This precision testing approach ensures accurate diagnosis and appropriate clinical management.

Who Should Consider This Genetic Test

This specialized genetic testing is recommended for individuals presenting with specific clinical symptoms and family history patterns:

  • Infants and children demonstrating congenital muscle weakness
  • Individuals with delayed motor milestones and muscle hypotonia
  • Patients exhibiting respiratory complications requiring support
  • Those with characteristic muscle biopsy findings showing fiber-type disproportion
  • Individuals with family history of congenital myopathies
  • Patients with unexplained progressive muscle weakness
  • Children experiencing feeding difficulties and failure to thrive
  • Individuals with scoliosis or other skeletal abnormalities associated with muscle weakness

Significant Benefits of Genetic Testing

Undergoing the SELENON Gene Myopathy with Fiber-Type Disproportion NGS Genetic DNA Test offers numerous advantages for patients and their families:

  • Definitive Diagnosis: Provides conclusive genetic confirmation of the condition
  • Personalized Treatment: Enables development of targeted management strategies
  • Family Planning: Offers crucial information for genetic counseling and reproductive decisions
  • Prognostic Insights: Helps predict disease progression and potential complications
  • Early Intervention: Facilitates timely implementation of supportive therapies
  • Research Contribution: Contributes to advancing understanding of rare neuromuscular disorders

Understanding Your Test Results

Our comprehensive genetic counseling services ensure you fully understand your test results and their implications:

Positive Result Interpretation

A positive result indicates the presence of pathogenic mutations in the SELENON gene, confirming the diagnosis of congenital fiber-type disproportion myopathy. This finding enables healthcare providers to implement appropriate management strategies, including respiratory support, physical therapy, and nutritional interventions tailored to the specific genetic findings.

Negative Result Interpretation

A negative result suggests that no pathogenic variants were detected in the SELENON gene. However, this does not completely rule out the possibility of a congenital myopathy, as other genetic or non-genetic factors may be involved. Further diagnostic evaluation may be recommended based on clinical presentation.

Variant of Uncertain Significance

In some cases, genetic variants of uncertain significance may be identified. These require careful interpretation by our genetic specialists and may necessitate additional family studies or follow-up testing to determine clinical relevance.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Pre-Test Requirements

Before undergoing testing, patients must provide:

  • Complete clinical history documentation
  • Participation in genetic counseling session
  • Development of detailed family pedigree chart
  • Informed consent for genetic testing

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and specialized neurologists ensures consistent, high-quality care regardless of your location.

Take Action Today

Don’t let uncertainty about neuromuscular symptoms delay your path to diagnosis and proper management. Our specialized team of genetic experts and neurologists is ready to provide the comprehensive testing and support you need. Early genetic diagnosis can significantly impact treatment outcomes and quality of life for individuals with congenital myopathies.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book the SELENON Gene Myopathy with Fiber-Type Disproportion NGS Genetic DNA Test. Our compassionate team will guide you through every step of the testing process and ensure you receive the personalized attention and expert care you deserve.